India's 'Mounjaro brides' turn to weight-loss drugs for pre-wedding transformation

Individuals face body-shaming and social stigma related to weight, with some experiencing rejection from prospective grooms' families based on appearance, driving risky off-label drug use.
If I am not happy, I don't feel confident at my wedding
A bride explains why she turned to weight-loss injections when diet and exercise fell short.

In the weeks before their weddings, a growing number of Indian brides and grooms are turning to prescription weight-loss injections like Mounjaro, seeking to meet the physical expectations embedded in one of life's most scrutinized rituals. The phenomenon, now formalized by clinics marketing 'Mounjaro bride' packages, reveals how ancient social pressures around appearance and matrimonial acceptance are finding new expression through modern pharmacology. As cheaper generics enter the market and regulatory oversight struggles to keep pace, the line between medical treatment and beauty standard grows harder to hold.

  • Clinics across India's major cities are packaging weight-loss injections alongside skin treatments and hair styling as standard pre-wedding offerings, signaling how deeply body pressure has penetrated the marriage ritual.
  • Over one in five obesity injection inquiries at some clinics now come from people with a single, fixed deadline — their wedding date — rather than a long-term health goal.
  • Women like Priya have faced outright rejection from prospective grooms' families because of their weight, turning pharmaceutical intervention into a survival strategy within the arranged marriage system.
  • The arrival of cheaper generic semaglutide is rapidly widening access to drugs intended only for medically eligible patients, alarming regulators and cautious physicians who warn against treating them as a cosmetic quick fix.
  • Most brides who used the injections stopped immediately after their weddings, raising urgent questions about what happens when the social deadline passes and the medical supervision ends.

At a New Delhi clinic called Klarity Skin Clinic, a new offering has appeared alongside the usual pre-wedding skin and hair treatments: a 'Mounjaro bride' package combining injections, nutrition guidance, and workout plans. It is part of a broader shift across India's cities, where weight-loss drugs have quietly become part of the pre-wedding transformation industry.

Eight doctors interviewed by Reuters described a surge in inquiries from soon-to-be brides and some grooms seeking these drugs specifically before their marriages. Mounjaro, made by Eli Lilly, has emerged as the drug of choice. At one New Delhi clinic, more than one in five obesity injection inquiries came from people with a wedding date circled on the calendar.

The pressure driving this demand is both intimate and structural. Aditi, a 26-year-old from Mumbai, tried diet and exercise before consulting a doctor in November. By her February wedding, she had lost ten kilograms. Priya, a 27-year-old tech worker from Bengaluru, described being told directly that her weight had cost her marriage proposals. She lost over twelve kilograms using oral semaglutide before switching to injectable Mounjaro. Her search for a groom continues. Akshitha, who married in Hyderabad last year, lost fifteen kilograms after a family doctor suggested the injections when wedding chaos left no room for the gym.

The market is expanding fast. Mounjaro sales doubled in the months after its Indian launch, and the country's obesity drug market is projected to reach the equivalent of 852 million dollars by 2030. Now, with semaglutide's patent expired, Indian manufacturers are releasing generics, broadening access well beyond the medically supervised context these drugs were designed for.

Regulators have raised concerns about misuse and unauthorized sales. Some doctors are drawing careful lines — prescribing only to those who are medically eligible and committed to lasting lifestyle changes. 'This cannot be a quick fix,' said Dr. Swati Pradhan of the Live Light clinic. The caution feels necessary: most of the brides who spoke to Reuters had stopped the injections shortly after their weddings, leaving open the question of what endures when the celebration ends and the scrutiny, for a moment, lifts.

In New Delhi, a wellness clinic called Klarity Skin Clinic has begun marketing what it calls a "Mounjaro bride" package—guided nutrition, injections, and workout plans designed to transform a woman's body before she walks down the aisle. It is not alone. Across India's major cities, clinics have started weaving weight-loss injections into the traditional pre-wedding transformation offerings of skin treatments and hair styling, recognizing a new and eager market: people desperate to shed pounds before their wedding day.

The shift reflects a broader trend. Eight doctors interviewed by Reuters reported a surge in inquiries from brides and some grooms asking specifically about weight-loss drugs in the months before their marriages. Mounjaro, made by Eli Lilly, has become the drug of choice—more sought after than Novo Nordisk's Wegovy. Rajat Goel, a bariatric surgeon at Hindivine Healthcare in New Delhi, said that over the past few months, more than one in five of his clinic's obesity injection inquiries came from people about to be married. Many arrived with a specific timeline: their wedding date.

The demand reflects the weight of tradition and expectation in Indian society. Weddings remain grand family affairs, often arranged by parents, and they carry with them unspoken rules about how a bride or groom should look. Physical appearance and financial status matter. For Aditi, a 26-year-old finance worker from Mumbai, the pressure was real. She tried diet and exercise, but when neither worked fast enough, she consulted a doctor in November for a weight-loss prescription. By her February wedding, she had lost ten kilograms. "When I see the result, I feel happy," she said. "If I am not happy, I don't feel confident." She is one of roughly half a dozen brides and one groom who spoke to Reuters about using these drugs before their weddings, though most asked not to be named because of the social stigma attached to weight and weight-loss.

For some, the pressure came not from within but from outside. Priya, a 27-year-old tech worker from Bengaluru, experienced direct rejection. "I've had men and their families reject my proposal because of my weight. I was told I was fat," she said. She began with an oral semaglutide, approved in India for diabetes but used off-label for weight loss, and lost more than twelve kilograms. She then switched to injectable Mounjaro. Her search for a groom continues. Akshitha, who married in Hyderabad last year, lost fifteen kilograms using the injections. A family doctor had suggested them when she worried about her weight and knew the chaos of wedding planning would leave no time for the gym or careful dieting.

The market for these drugs is expanding rapidly. Mounjaro and Wegovy launched in India last year, and Mounjaro sales doubled in the months after launch, making it the highest-selling drug in the world's most populous nation. The obesity drug market is forecast to reach 80 billion rupees—roughly 852 million dollars—by 2030. The lowest dose of Mounjaro costs 13,125 rupees per month; the highest, 25,781 rupees. Novo's Wegovy is cheaper, starting at 5,660 rupees. And now, with the patent on semaglutide expired, Indian drugmakers have begun selling generic versions, widening access further.

But access without oversight carries risk. The drugs are intended only for adults classified as obese or for those overweight with a medical condition like diabetes or hypertension. They are meant to be used under a doctor's supervision. Yet as cheaper versions flood the market, India's drug regulator has raised concerns about misuse and unauthorized sales. Some doctors are cautious. Dr. Swati Pradhan, founder of an obesity and metabolic wellness clinic called Live Light, said she prescribes the injections to soon-to-be brides only if they are medically eligible and show signs of other medical issues, and only while insisting on lifestyle changes for lasting results. "We understand the curiosity," she said, "but this cannot be a quick fix." Most of the brides who spoke to Reuters had discontinued the injections soon after their weddings. The question now is how many others will use them, and whether regulators can keep pace with demand that shows no sign of slowing.

Over the last few months, over 20% of the queries we've received for obesity injections are from to-be brides, who also openly give us a timeline on how soon they are getting married.
— Rajat Goel, bariatric surgeon at Hindivine Healthcare in New Delhi
We understand the curiosity, but this cannot be a quick fix.
— Dr. Swati Pradhan, founder of Live Light obesity and metabolic wellness clinic
La Conversación del Hearth Otra perspectiva de la historia
Inventor

Why are weight-loss drugs becoming so popular specifically around weddings in India?

Model

Because weddings in India are often arranged by families, and they carry real expectations about how a bride or groom should look. It's not just personal preference—it's family honor, social standing, the whole weight of tradition.

Inventor

But these are medical drugs, not cosmetics. Aren't doctors supposed to refuse off-label use?

Model

Some do. The careful ones prescribe only to people who are medically eligible and insist on lifestyle changes. But when a clinic is marketing a "Mounjaro bride" package, they're not really thinking about medical eligibility. They're thinking about a customer who will pay.

Inventor

What happens after the wedding?

Model

Most people stop taking the injections. The weight often comes back. But by then, the wedding is over, the photos are taken, and the family has seen what they wanted to see.

Inventor

Is there a class dimension here?

Model

Absolutely. These drugs are expensive—thousands of rupees a month. The people using them are finance workers, tech workers, people with money. But now that generic versions are flooding the market, that's changing. More people will have access, and regulators are worried about what happens when medical oversight disappears.

Inventor

What about the people who experience rejection because of their weight?

Model

That's the harder story. When a woman is told she's too fat to marry, when families reject her based on appearance alone, the drug becomes less about vanity and more about survival. It's a way to fight back against a system that has already decided her worth.

Inventor

Can that system change?

Model

Not as fast as a Mounjaro injection works. That's the real problem.

Contáctanos FAQ